Details for New Drug Application (NDA): 209048
✉ Email this page to a colleague
The generic ingredient in ASPIRIN AND DIPYRIDAMOLE is aspirin; dipyridamole. There are twenty-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the aspirin; dipyridamole profile page.
Summary for 209048
Tradename: | ASPIRIN AND DIPYRIDAMOLE |
Applicant: | Dr Reddys |
Ingredient: | aspirin; dipyridamole |
Patents: | 0 |
Pharmacology for NDA: 209048
Mechanism of Action | Cyclooxygenase Inhibitors |
Physiological Effect | Decreased Platelet Aggregation Decreased Prostaglandin Production |
Suppliers and Packaging for NDA: 209048
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ASPIRIN AND DIPYRIDAMOLE | aspirin; dipyridamole | CAPSULE, EXTENDED RELEASE;ORAL | 209048 | ANDA | NorthStar Rx LLC | 16714-964 | 16714-964-01 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16714-964-01) |
ASPIRIN AND DIPYRIDAMOLE | aspirin; dipyridamole | CAPSULE, EXTENDED RELEASE;ORAL | 209048 | ANDA | Dr. Reddy's Laboratories Inc | 43598-339 | 43598-339-60 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43598-339-60) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 25MG;200MG | ||||
Approval Date: | Oct 10, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription